- Home
- BSBK vs ZTEK Comparison
BSBK vs ZTEK Comparison
Compare BSBK & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BSBK | ZTEK |
|---|---|---|
| Founded | 1893 | 2008 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Banks | Major Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 106.1M | 89.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BSBK | ZTEK |
|---|---|---|
| Price | $8.16 | $0.72 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 5.7K | ★ 41.2K |
| Earning Date | 11-03-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $15,989,970.00 | $657,134.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $216.81 | ★ N/A |
| Revenue Growth | 31.80 | ★ 2225.73 |
| 52 Week Low | $6.59 | $0.62 |
| 52 Week High | $9.50 | $1.84 |
Technical Indicators
Market Signals| Indicator | BSBK | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 35.03 | 41.38 |
| Support Level | $8.14 | $0.70 |
| Resistance Level | $8.40 | $0.79 |
| Average True Range (ATR) | 0.17 | 0.05 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 9.45 | 15.62 |
Price Performance
Historical ComparisonAbout BSBK Bogota Financial Corp.
Bogota Financial Corp is a New Jersey-based bank. It offers personal and business banking services such as savings, certificates of deposits, online banking, loans, and many more. The Bank generally grants residential, commercial, and consumer loans to, and accepts deposits from customers in New Jersey.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.